• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对胃癌的杂化膜涂层纳米药物系统:VEGFR2/STAT3 信号通路。

A hybrid membrane coating nanodrug system against gastric cancer the VEGFR2/STAT3 signaling pathway.

机构信息

College of Biology, Hunan University, Changsha, 410082, China.

Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.

出版信息

J Mater Chem B. 2021 May 12;9(18):3838-3855. doi: 10.1039/d1tb00029b.

DOI:10.1039/d1tb00029b
PMID:33908580
Abstract

Although drug combination has proved to be an efficient strategy for clinic gastric cancer therapy, how to further improve their bioavailability and reduce the side effects are still challenges due to the low solubility and untargeted ability of drugs. Recently, newly emerging nanotechnology has provided an alternative for constructing new drug delivery systems with high targeting ability and solubility. In this study, a pH-responsive liposome (Liposome-PEO, LP) loaded with apatinib (AP) and cinobufagin (CS-1) was used for combinational therapy against gastric cancer after coating with a hybrid membrane (R/C). The results indicated that the constructed nanocomplex LP-R/C@AC not only efficiently killed tumor cells in vitro by inducing apoptosis, autophagy, and pyroptosis, but also significantly inhibited tumor invasion and metastasis via the VEGFR2/STAT3 pathway. Moreover, it showed stronger anti-tumor activity in gastric cancer-bearing mouse models, as compared to the sole drugs. A naturally-derived hybrid cell membrane coating bestowed nanocomplexes with enhanced biointerfacing including prolonged circulation time and targeting ability.

摘要

尽管药物联合已被证明是治疗临床胃癌的有效策略,但由于药物的低溶解度和非靶向性,如何进一步提高其生物利用度和降低副作用仍然是挑战。最近,新兴的纳米技术为构建具有高靶向性和溶解度的新型药物输送系统提供了一种替代方法。在这项研究中,载有阿帕替尼(AP)和华蟾素(CS-1)的 pH 响应脂质体(Liposome-PEO,LP)通过混合膜(R/C)包被用于联合治疗胃癌。结果表明,构建的纳米复合物 LP-R/C@AC 不仅通过诱导细胞凋亡、自噬和细胞焦亡有效地杀死了体外肿瘤细胞,还通过 VEGFR2/STAT3 通路显著抑制了肿瘤的侵袭和转移。此外,与单独使用药物相比,它在荷瘤小鼠模型中表现出更强的抗肿瘤活性。天然衍生的混合细胞膜涂层赋予纳米复合物增强的生物界面相互作用,包括延长的循环时间和靶向能力。

相似文献

1
A hybrid membrane coating nanodrug system against gastric cancer the VEGFR2/STAT3 signaling pathway.一种针对胃癌的杂化膜涂层纳米药物系统:VEGFR2/STAT3 信号通路。
J Mater Chem B. 2021 May 12;9(18):3838-3855. doi: 10.1039/d1tb00029b.
2
[The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].阿帕替尼通过Ras/Raf/MEK/ERK和JAK2/STAT3信号通路对食管癌细胞增殖、迁移及凋亡的抑制作用
Zhonghua Zhong Liu Za Zhi. 2019 Apr 23;41(4):263-275. doi: 10.3760/cma.j.issn.0253-3766.2019.04.005.
3
Apatinib regulates the cell proliferation and apoptosis of liver cancer by regulation of VEGFR2/STAT3 signaling.阿帕替尼通过调节VEGFR2/STAT3信号通路来调控肝癌细胞的增殖和凋亡。
Pathol Res Pract. 2019 Apr;215(4):816-821. doi: 10.1016/j.prp.2019.01.021. Epub 2019 Jan 18.
4
Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.阿帕替尼通过靶向信号转导和转录激活因子3(STAT3)抑制骨肉瘤的迁移、侵袭以及程序性死亡配体1(PD-L1)的表达。
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1695-1701. doi: 10.1016/j.bbrc.2017.12.032. Epub 2017 Dec 7.
5
Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma.阿帕替尼通过 VEGFR2/STAT3/BCL-2 信号通路促进骨肉瘤自噬和凋亡。
Cell Death Dis. 2017 Aug 24;8(8):e3015. doi: 10.1038/cddis.2017.422.
6
Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.阿帕替尼通过抑制卵巢癌细胞中的 VEGFR2/AKT1/SOX5/GLUT4 信号通路来抑制糖酵解。
Cell Oncol (Dordr). 2019 Oct;42(5):679-690. doi: 10.1007/s13402-019-00455-x. Epub 2019 Jul 20.
7
Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.阿帕替尼通过抑制 VEGFR-2 增强顺铂对三阴性乳腺癌的抗肿瘤活性。
Pathol Res Pract. 2019 Jul;215(7):152422. doi: 10.1016/j.prp.2019.04.014. Epub 2019 Apr 28.
8
Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.线粒体 ROS 积累抑制 JAK2/STAT3 通路是 CYT997 诱导胃癌自噬和凋亡的关键调节剂。
J Exp Clin Cancer Res. 2020 Jun 23;39(1):119. doi: 10.1186/s13046-020-01621-y.
9
Enhancing the chemotherapy effect of Apatinib on gastric cancer by co-treating with salidroside to reprogram the tumor hypoxia micro-environment and induce cell apoptosis.通过与红景天苷联合治疗来增强阿帕替尼对胃癌的化疗效果,以重新编程肿瘤缺氧微环境并诱导细胞凋亡。
Drug Deliv. 2020 Dec;27(1):691-702. doi: 10.1080/10717544.2020.1754528.
10
Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.百里醌在体内和体外通过STAT3途径抑制胃癌细胞增殖。
World J Gastroenterol. 2016 Apr 28;22(16):4149-59. doi: 10.3748/wjg.v22.i16.4149.

引用本文的文献

1
Biomembrane-coated nanosystems as next-generation delivery systems for the treatment of gastrointestinal cancers.生物膜包被的纳米系统作为治疗胃肠道癌症的下一代递送系统。
Bioeng Transl Med. 2025 Feb 26;10(4):e70006. doi: 10.1002/btm2.70006. eCollection 2025 Jul.
2
Application of smart responsive nanomaterials in the theranostics of gastrointestinal malignancies: Current status and future perspectives.智能响应性纳米材料在胃肠道恶性肿瘤诊疗中的应用:现状与未来展望
Coord Chem Rev. 2025 Jul 15;535. doi: 10.1016/j.ccr.2025.216641. Epub 2025 Mar 29.
3
Cinobufagin inhibits hepatocellular carcinoma EMT-like stemness via VEGF/VEGFR2 autocrine signaling.
华蟾毒精通过VEGF/VEGFR2自分泌信号抑制肝细胞癌的EMT样干性。
Discov Oncol. 2025 May 26;16(1):930. doi: 10.1007/s12672-025-02707-9.
4
Bufotalin loaded biomimetic nanodrug for combined chemo/photodynamic therapy of cancer.负载蟾毒灵的仿生纳米药物用于癌症的化学/光动力联合治疗
Mater Today Bio. 2025 Mar 18;32:101684. doi: 10.1016/j.mtbio.2025.101684. eCollection 2025 Jun.
5
Nanomaterials evoke pyroptosis boosting cancer immunotherapy.纳米材料引发细胞焦亡以促进癌症免疫治疗。
Acta Pharm Sin B. 2025 Feb;15(2):852-875. doi: 10.1016/j.apsb.2024.11.011. Epub 2024 Nov 23.
6
Cinobufagin: Unveiling the hidden bufadienolide's promise in combating alimentary canal cancer development and progression - a comprehensive review.华蟾毒精:揭示隐藏的蟾二烯羟酸内酯在对抗消化道癌症发生和发展方面的前景——一篇综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 20. doi: 10.1007/s00210-025-03902-9.
7
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs.基于全基因表达谱鉴定肝细胞癌亚型以预测预后和潜在治疗药物
Biomedicines. 2025 Jan 20;13(1):236. doi: 10.3390/biomedicines13010236.
8
Theranostic Approaches for Gastric Cancer: An Overview of In Vitro and In Vivo Investigations.胃癌的诊疗一体化方法:体外和体内研究综述
Cancers (Basel). 2024 Sep 28;16(19):3323. doi: 10.3390/cancers16193323.
9
Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom.基于蟾皮和蟾毒液活性成分的联合抗肿瘤策略。
Drug Des Devel Ther. 2024 Aug 9;18:3549-3594. doi: 10.2147/DDDT.S469832. eCollection 2024.
10
Advances on Delivery System of Active Ingredients of Dried Toad Skin and Toad Venom.干蟾皮和蟾酥活性成分给药系统的研究进展。
Int J Nanomedicine. 2024 Jul 18;19:7273-7305. doi: 10.2147/IJN.S469742. eCollection 2024.